About Pluslife
Pluslife is established in Guangzhou, China in 2017. With our R&D team that combines experienced and talented researching and developing personnel that more than 60% of them are certificated Ph.Ds or Masters, our team satisfies the needs of applying cutting-edge genetic technologies to develop an independent and innovative molecular POCT diagnostic system that provides complete and economic solutions to our users. In order to fulfill our missions of constantly improving accuracy and speed of detection and solution, Pluslife always values our R&D talents' determinations and passions on innovating fine biological and genetic technologies. Hence, we are now holding dozens of patents of technologies on multiple fields that will contribute to our further research and development.
In over 40 countries, Pluslife's products are available in various applications, including hospitals, clinics, pharmacies, laboratories, airports, households, etc.
Corporate Positioning
Revolutionizing and Decentralizing Infectious Disease Diagnosis with Innovative, Rapid, Accurate, and Affordable Molecular POCT Solutions
-
2018
Establish an independent intellectual property core raw material enzyme screening platform
-
2019
Obtained the Guangzhou Industry Leading Talent Agglomeration Project · Entrepreneurship Leading Team
-
2020
▶ Participated in the key scientific research project of COVID-19 prevention and control in Guangzhou
▶ RHAM technology completed research and development -
2021
Completed Series A financing of 100 million yuan
COVID-19 test kit and test platform MiniDock are launchedISO 13485 certification obtained
-
2022
▶ Product entering mass production
▶ Recommended projects for rapid nucleic acid testing by the Ministry of Science and Technology, with priority evaluation
▶ Parallel development of multiple pipelines
▶ Series A+financing of 50 million yuan -
2023
▶ Awarded the title of "Guangdong Province 2022 Specialized, Refined, Special, and New Small and Medium sized Enterprises"
▶ Successfully developed over 30 types of testing products
▶ Register and advertise in multiple countries and regions
▶ Collaborate with well-known international NGOs such as FIND and BMGF -
2024
● Publication of clinical validation data in scientific journals
● Pluslife's RHAM patented technology accuracy validated by authoritative international academic institutions
● Invited to attend the 3rd National Tuberculosis Innovation Forum and the 4th International Forum on Tuberculosis R&D Cooperation
Milestone
Technology Platform
Independently developed patented technology RHAM
——
Independently developed patented technology RHAM
——
RHAM technology effectively overcomes the shortcomings of non-specific amplification (LAMP), insufficient sensitivity (RPA), long reaction time (NASBA), insufficient compatibility and patent limitation (CRISPR) of similar isothermal amplification technologies, and truly achieves the landing of high sensitivity and high specificity nucleic acid POCT rapid detection.
Autonomous raw material enzyme
——
Autonomous raw material enzyme
——
All product raw materials are self-produced by enzymes, with a new generation of enzyme directed evolution platform and protein expression platform, which can achieve large-scale production of protein raw materials at the level of millions per month.
Autonomous POCT process&fully automated production line
——
Autonomous POCT process&fully automated production line
——
With independent patented technology, the entire production line is automated, and the testing reagent kit can reach a monthly production capacity of millions of people.
Contact Us
Tel: +86-20-31703986
E-mail: market@pluslife.com (Business Enquiry)
service@pluslife.com (After-Sales & Technical Support)
Add: 3F-Block E, Runhui Science & Technology Park, No.18 Shenzhou RD, Huangpu District, Guangzhou, Guangdong, China
Copyright © Established